Brilliance Asset Management LTD Zai Lab LTD Transaction History

Brilliance Asset Management LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$13.72 - $21.55 $8,245 - $12,951	601 Added 0.14%	436,527 $7.57 Million
Q4 2023 Feb 13, 2024	BUY	$22.97 - $30.58 $6.4 Million - $8.53 Million	278,841 Added 177.51%	435,926 $11.9 Million
Q3 2023 Nov 13, 2023	BUY	$22.72 - $31.49 $3.57 Million - $4.95 Million	157,085 New	157,085 $3.82 Million
Q3 2022 Nov 09, 2022	SELL	$34.2 - $51.69 $44.6 Million - $67.4 Million	-1,303,289 Reduced 98.43%	20,775 $711,000
Q2 2022 Aug 12, 2022	SELL	$23.14 - $49.68 $7.12 Million - $15.3 Million	-307,823 Reduced 18.86%	1,324,064 $45.9 Million
Q1 2022 Apr 29, 2022	SELL	$27.77 - $64.4 $46.9 Million - $109 Million	-1,689,083 Reduced 50.86%	1,631,887 $71.8 Million
Q4 2021 Feb 11, 2022	BUY	$54.9 - $105.21 $12.6 Million - $24.1 Million	228,750 Added 7.4%	3,320,970 $209 Million
Q3 2021 Nov 12, 2021	SELL	$105.0 - $178.37 $5.15 Million - $8.75 Million	-49,062 Reduced 1.56%	3,092,220 $326 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $27.2 Million - $39.1 Million	217,393 Added 7.44%	3,141,282 $556 Million
Q1 2021 May 14, 2021	SELL	$126.27 - $191.71 $15.5 Million - $23.6 Million	-123,087 Reduced 4.04%	2,923,889 $390 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $194 Million - $320 Million	2,362,244 Added 344.99%	3,046,976 $412 Million
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $50.2 Million - $61.3 Million	684,732 New	684,732 $56.9 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.62B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Brilliance Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Brilliance Asset Management LTD with notifications on news.